MT-302Myeloid TherapeuticsClinicalTrials.govsolid tumors
…2 in advanced solid tumors with high rates of TROP2 expression. MT-302 was delivered off the shelf with intravenous administration (an…
1articles mentioning drugs
7drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: MT-302 ×
MT-302
This drug is selected. Its supporting articles are shown below.